AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-negative Breast Cancer
Interventions: DRUG: AT regimen|DRUG: TP regimen
Sponsor: Sichuan Provincial People's Hospital